Dark Daily Webinar: Tougher Lab Regulations and New Legal Issues in 2018: More Frequent Payer Audits, Problems with Contract Sales Reps, Increased Liability for CLIA Lab Directors, Proficiency Testing Violations, and More

Join the webinar, Wednesday Nov. 8th – Register Now

Attention clinical laboratory and pathology group execs: learn the steps you and your management team need to take NOW to mitigate risk and keep your lab organization financially strong!

Looking forward into 2018, Medicare Part B clinical laboratory price cuts are not the only big story. Other significant threats can upend your laboratory, such as tougher payer audits with higher recovery demands or new federal and state regulatory rules that increase the personal liability of CLIA lab directors and lab executives.

The list of regulatory, compliance, and managed care threats that must be addressed by clinical labs and pathology group practices in 2018 is lengthy. Each comes with the potential of government sanctions, exclusion from provider networks, large recoupment demands, and greater risk for individual liability of lab directors and lab managers that can include jail time, sizeable fines, and exclusion from federal health programs.

Expert Speakers:

Jeffrey J. Sherrin, President and Partner, O’Connell & Aronowitz, Albany, NY

David W. Gee, Partner, Davis Wright Tremaine, LLP, Seattle, WA

Richard S. Cooper, Chair, National Healthcare Practice Group, McDonald Hopkins, LLC, Cleveland, OH